PROTHENA

Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases... Prothena is focused on accelerating pioneering science from bench to bedside with a singular focus on creating a better future for people with neurodegenerative and rare peripheral amyloid diseases.

Also known as: Prothena Corporation, Prothena Corporation plc

Primary location: Brisbane United States